Showing results (1671-1680 of 1,963) with videos related to

Sort By:
Pageof 197
EMBO Molecular Medicine|March 1, 2023
Metabolic rewiring in keratinocytes by miR-31-5p identifies therapeutic intervention for psoriasisMao-Jie Wang, Huan-Jie Huang, Yong-Yue Xu, et al.
Targeted Oncology|July 21, 2019
Prospective Study of Drug-induced Interstitial Lung Disease in Advanced Breast Cancer Patients Receiving Everolimus Plus ExemestaneAnnelieke E C A B Willemsen, Jolien Tol, Nielka P van Erp, et al.
European Journal of Cancer (Oxford, England : 1990)|December 22, 2017
A randomised phase II trial of docetaxel versus docetaxel plus carboplatin in patients with castration-resistant prostate cancer who have progressed after response to prior docetaxel chemotherapy: The RECARDO trialEsther W Bouman-Wammes, H Pieter van den Berg, Linda de Munck, et al.
Cancer Research|October 18, 2002
Potential of the conditionally replicative adenovirus Ad5-Delta24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapyMartine L M Lamfers, Jacques Grill, Clemens M F Dirven, et al.
Blood|December 1, 1994
Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation for (severe) combined immunodeficiencyJ E van Leeuwen, M J van Tol, A M Joosten, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 22, 2024
Modeling creatine-kinase MB concentrations following coronary artery bypass graftingJamie L Romeo, Pieter A Vriesendorp, Kim Gerritsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patientsI Jolanda M de Vries, W Joost Lesterhuis, Nicole M Scharenborg, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 2012
Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro)H J Meulenbeld, E D van Werkhoven, J L L M Coenen, et al.
Cancer Research|October 19, 2005
Tissue inhibitor of metalloproteinase-3 expression from an oncolytic adenovirus inhibits matrix metalloproteinase activity in vivo without affecting antitumor efficacy in malignant gliomaMartine L M Lamfers, Davide Gianni, Ching-Hsuan Tung, et al.
Journal of Structural Biology|December 25, 2012
Localization of fluorescently labeled structures in frozen-hydrated samples using integrated light electron microscopyF G A Faas, M Bárcena, A V Agronskaia, et al.
Pageof 197